Opendata, web and dolomites

NiGlucoMon

A Non-Invasive GLUCOse MONitoring device for diabetics based on Stimulated Raman Spectroscopy in a quick, cheap and painless method.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NiGlucoMon project word cloud

Explore the words cloud of the NiGlucoMon project. It provides you a very rough idea of what is the project "NiGlucoMon" about.

60    optics    usable    promises    formulated    measuring    created    vessel    diabetics    biggest    signal    inexpensive    energy    avoidance    scattering    invasive    little    plan    price    once    levels    spectrum    people    readiness    analyzing    dispersing    fail    ulcers    normal    strips    measured    nerve    complications    technique    obstacles    times    solution    transfer    recommended    disliking    today    collecting    packaging    chronic    implications    manner    serious    disease    damage    power    foot    prick    patent    leg    uncontrolled    overcome    least    diabetic    risk    interact    transferred    ratio    proportional    beams    beam    proof    molecules    undergoes    injury    monitor    meter    day    pain    carry    amputations    light    protocol    blood    experimental    blindness    spectroscopy    kidney    expensive    diabetes    infection    noise    heart    integration    complete    raman    finger    stimulated    isolating    sight    concentration    glucose    painless    quick   

Project "NiGlucoMon" data sheet

The following table provides information about the project.

Coordinator
2M ENGINEERING LIMITED 

Organization address
address: SIDNEY STREET 80
city: FOLKSTONE
postcode: CT19 6HQ
website: www.2mel.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.trigonamedical.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-10-01   to  2015-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    2M ENGINEERING LIMITED UK (FOLKSTONE) coordinator 50˙000.00

Map

 Project objective

Today, diabetics must carry out a “finger prick” test as part of their blood glucose level management. It is recommended to do this test at least 4 times a day. Many diabetics fail to do so even once for a number of reasons: pain avoidance, disliking the sight of blood, cost of the test strips, the test protocol and the risk of infection. This failure to manage blood glucose levels has serious long term implications. Heart disease and blood vessel disease are the biggest complications that people with uncontrolled diabetes face. Blood vessel damage or nerve damage also lead to chronic foot and leg ulcers called diabetic foot that can result in amputations. More than 60% of leg and foot amputations not related to an injury are due to diabetes which is also the cause of new blindness and kidney disease. Our solution is a non-invasive glucose monitor that will allow people with diabetes to monitor their blood glucose levels in a quick and painless manner, for a low price. When using normal Raman Spectroscopy very little light undergoes Raman scattering, therefore high integration times are required to achieve a usable signal-to-noise ratio. Expensive optics are necessary for collecting, isolating and dispersing the light. Our technique and system packaging promises to overcome all of these obstacles. We use Stimulated Raman Spectroscopy, created when two light beams interact with each other in the presence of glucose. The energy is transferred from one beam of light to the other, and this transfer is proportional to the number of glucose molecules present. By measuring this energy transfer using a simple and inexpensive power meter, the glucose concentration is measured without the need for dispersing the light and analyzing the Raman Spectrum. A patent has been applied for. We have completed the Technology Readiness Level 2 (technology concept formulated) and plan to complete Technology Readiness Level 3 (Experimental Proof of concept) in this project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGLUCOMON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGLUCOMON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More